Evista and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evista (raloxifene hydrochloride) and Adalat (nifedipine). Common drug interactions include headache among females.

The phase IV clinical study analyzes what interactions people have when they take Evista and Adalat. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

93 people who take Evista and Adalat together, and have interactions are studied.

What are the common drug interactions of Evista and Adalat, by gender? *:

female:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Altered state of consciousness (altered state of mind)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Osteitis (a general term for inflammation of bone)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depressed mood
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

male:

n/a

What are the common drug interactions of Evista and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gastric mucosa erythema (reddened mucosa of stomach)
Gastritis (inflammation of stomach)
Headache (pain in head)
Oedema (fluid collection in tissue)
Foot fracture
Furuncle (infection of the hair follicle)

50-59:

n/a

60+:

Arthralgia (joint pain)
Decreased appetite
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Osteitis (a general term for inflammation of bone)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depressed mood
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Gastric ulcer (stomach ulcer)
Gastroenteritis (inflammation of stomach and intestine)

What are the existing conditions these people have? *

Cerebral Infarction (less blood supply to brain resulting tissue damage): 8 people, 8.60%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 6.45%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 6.45%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.38%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 5 people, 5.38%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously